Skip to content

Medpace Voice

Company Spotlight

Medpace Expands Medical Leadership Team with Expert in Parkinson’s Disease 

  • October 20, 2025

Neuroscience and Cognition and brings extensive expertise in the design and execution of Parkinson’s disease research. Additionally, she has over...

Clinical Development

Redefining Midlife Care – Clinical Development Imperatives for Perimenopause, Menopause, and Postmenopausal | World Menopause Day

  • October 16, 2025

Menopause remains one of the most underrepresented areas in clinical research. Yet this life stage, marked by profound physiological transitions and long-term health implication, presents…

Company Spotlight

Medpace Recognized as CRO Recipient of the 2025 SCRS Eagle Award

  • October 9, 2025

Medpace is honored to announce that we have been awarded the SCRS 2025 CRO Eagle Award. Since 2009, the SCRS...

Clinical Development

[On-Demand Webinar] Advancing Obesity Clinical Development: Emerging Strategies for Next‑Gen Trials

  • October 6, 2025

With global recognition of obesity as a complex, chronic disease impacting over one billion people, advancements in obesity clinical development...

Clinical Development

Bridging Early-Phase Insight to Late Phase Success | Inside Medpace’s New Phase I Unit Facility 

  • August 28, 2025

With the launch of a newly built, state-of-the-art clinical pharmacology unit, Medpace strengthens its position as a strategic early phase...

Clinical Development

Reflections from the 2025 ERA Congress: Insights on the Future of Kidney Research

  • July 21, 2025

Representatives from Medpace’s medical and operational teams engaged in critical discussions around trial innovation, therapeutic advances, and evolving standards of...

Company Spotlight

Q&A with Two Medpace Rheumatology Medical Experts: Innovations and Expert Insights 

  • July 14, 2025

In this brief interview, we explore the expertise of two Medpace Rheumatologists.

Clinical Development

Top 3 Key Takeaways from ENCALS 2025

  • July 1, 2025

Medpace Medical and Clinical Operations Experts Share Key Insights from the ENCALS Meeting

Clinical Development

SNMMI 2025 Highlights | Radiopharmaceuticals Reshaping Oncology Trials

  • July 1, 2025

Radiopharmaceuticals are reshaping oncology trials through integrated imaging, dosimetry, and therapeutic precision. Following SNMMI, Medpace experts share considerations for biopharma Sponsors navigating the scientific, operational,…

Company Spotlight

Medpace Recognized with WCG Pinnacle Award for Professionalism and Communication in Site Relationships

  • June 24, 2025

Medpace Recognized with 2025 WCG Pinnacle Award for Professionalism and Communication in Site Relationships